The largest database of trusted experimental protocols

3 protocols using bm0627

1

Western Blot Analysis of Wnt Pathway Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies against Snail1 (cat. no. 125918) were purchased from GeneTex, Inc. (Irvine, CA, USA). Primary antibodies against Wnt1 (ab85060), Wnt8a (ab130930), phosphorylated glycogen synthase kinase 3β (P-GSK3β; ab130937) and GAPDH (ab37168) were obtained from Abcam (Cambridge, UK). Primary antibodies against Wnt3a (bs1700R) and Wnt5a (bs1948R) were purchased from BIOSS (Beijing, China). The primary antibody against Wnt11 (sc50360) was purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). Antibodies against β-catenin (BA0426) and β-actin (BM0627) were obtained from Wuhan Boster Biological Technology, Ltd. (Wuhan, China). The antibody against GSK3β (22104-1-AP) was purchased from Wuhan Sanying Biotechnology (Wuhan, China). The bicinchoninic acid (BCA) protein assay kit was purchased from Beyotime Institute of Biotechnology (Haimen, China). TRIzol (252250AX) was obtained from Aidlab Biotechnologies Co., Ltd. (Beijing, China). M-MLV Reverse Transcriptase (RNase H; CO2010A) and ddH2O (DNase/RNase Free; C1D230A) were purchased from GeneCopoeia, Inc. (Rockville, MD, USA) and RNase Inhibitor (I21222) was obtained from TransGen Biotech, Inc. (Beijing, China).
+ Open protocol
+ Expand
2

Quantifying Phospho-GSK-3β and β-Catenin

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure the protein expression of phosphorylaed GSK-3β at Tyr-216 (p-Tyr216 GSK-3β) and β-catenin, we conducted western blot analysis. Total proteins were separated on 10% SDS-PAGE gels and then transferred onto polyvinylidene fluoride blotting membranes. After blocking non-specific binding with 5% BSA in Tween-Tris-buffered saline, the membranes were incubated with the following primary antibodies: anti-p-Tyr216 GSK-3β (ab75745; 1:500 dilution; Abcam, Cambridge, CA, USA), anti-β-catenin (ab32572; 1:1,000 dilution; Abcam) and anti-β-actin (BM0627; 1:200 dilution; Wuhan Boster Biological Technology, Ltd.) antibodies overnight. The membranes were then incubated for 2 h with secondary antibodies (ZDR-5306, 1:2,000 dilution; Zhongshan Golden Bridge Biotechnology, Co., Ltd., Beijing, China) labeled with horseradish peroxidase. The immunoreactive proteins on the blots were visualized using ECL™ western blot detection reagents, and the signals were detected using Image Station 4000R (Kodak, Rochester, NY, USA).
+ Open protocol
+ Expand
3

Investigating PTEN/Akt Signaling in Angiogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of PTEN was assessed by western blot analysis, and its expression in the samples was normalized to β-actin expression. Cells were lysed in RIPA buffer with freshly added protease inhibitor. Total lysates were separated on SDS-PAGE gels and transferred to polyvinylidene uoride (PVDF) membranes (Millipore). The immunoblots were blocked with 5% fat-free milk and they were incubated at 4˚C overnight with primary antibodies anti-PTEN (1:1000, Cell Signaling Technology), anti-β-actin (1:1000, BM0627; Wuhan Boster Biological Technology, Ltd., Wuhan, China). Akt (Ser473) (1:1000, Cell Signaling Technology) phosphorylation were examined by using phospho-speci c antibodies. Total protein was determined using anti-Akt antibodies. After incubation with the secondary antibody, the membranes were visualized with an enhanced chemiluminescence system kit (Millipore, USA), according to the manufacturer's protocol. To explore whether miR-21 promote angiogenesis in tumor microenvironment by PTEN/Akt signaling pathway, the recipient cells were treated PI3K/Akt inhibitor LY294002 which was obtained from Beyotime Biotechnology (Nantong, China) with a nal concentration of 60μM.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!